全文获取类型
收费全文 | 43115篇 |
免费 | 3016篇 |
国内免费 | 148篇 |
专业分类
耳鼻咽喉 | 467篇 |
儿科学 | 1377篇 |
妇产科学 | 1176篇 |
基础医学 | 5938篇 |
口腔科学 | 494篇 |
临床医学 | 6276篇 |
内科学 | 8317篇 |
皮肤病学 | 714篇 |
神经病学 | 4364篇 |
特种医学 | 810篇 |
外国民族医学 | 1篇 |
外科学 | 3468篇 |
综合类 | 770篇 |
一般理论 | 42篇 |
预防医学 | 5011篇 |
眼科学 | 883篇 |
药学 | 2987篇 |
中国医学 | 79篇 |
肿瘤学 | 3105篇 |
出版年
2023年 | 224篇 |
2022年 | 469篇 |
2021年 | 865篇 |
2020年 | 480篇 |
2019年 | 803篇 |
2018年 | 933篇 |
2017年 | 725篇 |
2016年 | 805篇 |
2015年 | 978篇 |
2014年 | 1310篇 |
2013年 | 1995篇 |
2012年 | 3016篇 |
2011年 | 3174篇 |
2010年 | 1616篇 |
2009年 | 1560篇 |
2008年 | 2848篇 |
2007年 | 3075篇 |
2006年 | 3157篇 |
2005年 | 3097篇 |
2004年 | 3012篇 |
2003年 | 2832篇 |
2002年 | 2621篇 |
2001年 | 374篇 |
2000年 | 278篇 |
1999年 | 374篇 |
1998年 | 487篇 |
1997年 | 418篇 |
1996年 | 380篇 |
1995年 | 362篇 |
1994年 | 267篇 |
1993年 | 297篇 |
1992年 | 206篇 |
1991年 | 211篇 |
1990年 | 186篇 |
1989年 | 180篇 |
1988年 | 191篇 |
1987年 | 152篇 |
1986年 | 131篇 |
1985年 | 151篇 |
1984年 | 190篇 |
1983年 | 186篇 |
1982年 | 237篇 |
1981年 | 176篇 |
1980年 | 184篇 |
1979年 | 110篇 |
1978年 | 107篇 |
1977年 | 113篇 |
1976年 | 87篇 |
1975年 | 71篇 |
1974年 | 80篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
Susan B Fowler Michael Moussouttas Barbara Mancini 《The Journal of neuroscience nursing》2005,37(4):220-223
Metabolic syndrome is associated with increased risk for cardiovascular and cerebrovascular disease. The World Health Organization and National Cholesterol Education Program Adult Treatment Panel III have identified physiologic abnormalities associated with metabolic syndrome, including impaired glucose metabolism, high blood pressure, elevated cholesterol levels, and abdominal obesity. It is estimated that 47 million Americans have metabolic syndrome. A variety of therapies may help reduce the incidence and risk, including diet, weight loss, physical exercise, glycemic control, and pharmacological treatments. Nursing care is focused on developing an individualized plan of care that includes family members and providing education, psychosocial support, close monitoring, and continued follow-up to ensure adherence and success in achieving patient outcomes. 相似文献
22.
23.
Anna Krygowska-Wajs William P. Cheshire Zbigniew K. Wszolek Alicja Hubalewska-Dydejczyk Barbara Jasinska-Myga Matthew J. Farrer Marek Moskala Anna Sowa-Staszczak 《Parkinsonism & related disorders》2009,15(9):692-696
ObjectiveTo assess for the presence of gastric dysmotility in familial and sporadic Parkinson disease (PD).Methods10 subjects with familial Parkinson disease (fPD), 35 subjects with sporadic Parkinson disease (sPD), and 15 controls, all from academic tertiary care movement disorders centers, were studied. fPD was defined as the presence of at least 2 affected individuals within 2–3 consecutive generations in a family. Molecular genetic analysis has not revealed, thus far, any known genomic abnormality in these families. Gastric emptying was assessed by dynamic abdominal scintigraphy over 92 min following ingestion of a solid meal containing 99mTc-labeled colloid of 40 MBq activity. The main outcome measures were gastric emptying half-time and radiotracer activity over the gastric area at 46 and at 92 min.ResultsGastric emptying time was delayed in 60% of subjects with PD. In comparison to mean t1/2 of 38 ± 7 min in controls, mean t1/2 was 58 ± 25 min in fPD (p = 0.02) and 46 ± 25 min in sPD (p = 0.10). Both fPD and sPD groups included subjects with delayed gastric emptying at an early stage of disease.ConclusionsPatients with fPD showed significantly delayed gastric emptying in comparison to normal age-matched individuals. Further studies of gastrointestinal dysfunction in PD, particularly fPD, are warranted. 相似文献
24.
25.
Sheela R Geraghty Barbara S Davidson Barbara B Warner Amy L Sapsford Jeanne L Ballard Betsy A List Rachel Akers Ardythe L Morrow 《Journal of human lactation》2005,21(1):59-66
Although there are well-established clinical human milk banks in the United States, there are no milk banks specifically intended to foster research on human milk. The authors' goal was to establish a milk bank with a core data set to support exploratory and hypothesis-driven studies on human milk. Donations to the Cincinnati Children's Research Human Milk Bank are accepted within the context of ongoing, hypothesis-driven research or on an ad hoc basis. Donors must give informed consent, and scientists wishing to use the samples must have Institutional review board approval for their use. Development of more research human milk banks can potentially provide resources for multidisciplinary collaboration and advance the study of human milk and lactation. 相似文献
26.
Barbara Sibbald 《Canadian Medical Association journal》2005,172(9):1169
27.
Practical management of patients with non-small-cell lung cancer treated with gefitinib. 总被引:7,自引:0,他引:7
Neelam T Shah Mark G Kris William Pao Leslie B Tyson Barbara M Pizzo Murk-Hein Heinemann Leah Ben-Porat Dana L Sachs Robert T Heelan Vincent A Miller 《Journal of clinical oncology》2005,23(1):165-174
PURPOSE: The use of gefitinib, the first drug approved to inhibit the epidermal growth factor receptor tyrosine kinase, is indicated in patients with non-small-cell lung cancer with tumors progressive after chemotherapy. The unique mechanism of action of this agent leads to distinctive patterns of response and toxicity in persons with lung cancer. Many of the principles of management relevant to gefitinib are distinct from those with conventional cytotoxic drugs. To meet this need, we present practical guidelines on the use of gefitinib in patients with non-small-cell lung cancer. METHODS: This article reviews gefitinib's indications, dosing, response phenomena, and patterns of relapse in individuals with radiographic response. RESULTS: We present our recommendations for the management of rash and diarrhea caused by this agent. CONCLUSION: This information can guide practitioners and help them inform their patients about what to expect when they receive gefitinib. 相似文献
28.
29.
Nicola Martinelli Domenico Girelli Paolo Ferraresi Oliviero Olivieri Barbara Lunghi Franco Manzato Roberto Corrocher Francesco Bernardi 《Blood coagulation & fibrinolysis》2007,18(2):125-129
A common factor V gene haplotype, the FVR2 haplotype (FVHR2), has been associated with a reduced cofactor activity in activated protein C-mediated activated factor VIII inactivation. Our aim was to investigate the role of FVHR2 as a possible determinant of factor VIII levels in a population study. A total of 516 individuals (401 men, 115 women; mean age 58.4 +/- 10.8 years) were enrolled within the frame of a regional cardiovascular survey, characterized for factor VIII coagulant activity (FVIII:c) and factor V coagulant activity (FV:c) levels, and genotyped for factor V polymorphisms. In men without signs of overt inflammation, FVHR2 carriers had higher levels of FVIII:c than noncarriers (154 IU/dl, 95% confidence interval = 143-166 versus 142 IU/dl, 95% confidence interval = 138-147; P = 0.045) and were more represented in individuals with high (> or = 150 IU/dl) FVIII:c levels (21.2 versus 10.8%; odds ratio = 2.27, 95% confidence interval = 1.17-4.39 after adjustment for age, blood group and high-sensitivity C-reactive protein levels). In conclusion, this clinical report suggests the common FVHR2 as a possible independent determinant of FVIII:c levels. The report concomitantly addresses the relationship between factor V and factor VIII levels and supports the hypothesis of a mild prothrombotic role of FVHR2 by means of increased factor VIII levels. 相似文献
30.
Beyond C4d: Other Complement-Related Diagnostic Approaches to Antibody-Mediated Rejection 总被引:3,自引:0,他引:3
William M. Baldwin III Edward K. Kasper rea A. Zachary Barbara A. Wasowska E. Rene Rodriguez 《American journal of transplantation》2004,4(3):311-318
Complement is a multifunctional system of receptors and regulators as well as effector molecules. Both the pathogenic and diagnostic power of complement is based on the capacity of the complement system to amplify innate and adaptive immunity. This amplification is accomplished through two strategies: (1) enzymatic reactions in the complement cascade, and (2) stimulation of leukocytes, platelets and parenchymal cells through specific receptors or receptor-independent pore formation. The mechanisms by which complement mediates and modifies nonspecific inflammation, antibody-mediated injury and T-cell responses are of particular significance to the pathogenesis of transplant rejection. Understanding the mechanisms by which complement integrates the interactions of leukocytes, platelets and parenchymal cells offers opportunities to further refine the diagnosis of rejection. 相似文献